HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alberto Piperno Selected Research

Familial apoceruloplasmin deficiency

3/2020Different cortical excitability profiles in hereditary brain iron and copper accumulation.
1/2020Inherited iron overload disorders.
1/2018Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia.
3/2016Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia?
6/2015Movement disorders and brain iron overload in a new subtype of aceruloplasminemia.
11/2010Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders.
3/2005MR imaging of cerebral cortical involvement in aceruloplasminemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alberto Piperno Research Topics

Disease

28Iron Overload
10/2021 - 08/2002
25Hemochromatosis (Bronze Diabetes)
12/2021 - 06/2002
6Hyperferritinemia
01/2021 - 10/2006
6Hypoxia (Hypoxemia)
06/2018 - 10/2009
6Fibrosis (Cirrhosis)
07/2016 - 12/2005
4Anemia
01/2020 - 01/2017
4Liver Cirrhosis (Hepatic Cirrhosis)
01/2018 - 08/2002
4beta-Thalassemia (Cooley's Anemia)
03/2016 - 05/2004
4Non-alcoholic Fatty Liver Disease
01/2012 - 10/2006
3Neurologic Manifestations (Neurological Manifestations)
01/2020 - 01/2018
3Thalassemia
01/2017 - 10/2009
3Infections
03/2011 - 12/2005
2Iron Deficiencies
01/2022 - 03/2004
2Hepatolenticular Degeneration (Wilson's Disease)
03/2020 - 03/2005
2Neurodegenerative Diseases (Neurodegenerative Disease)
03/2020 - 07/2013
2Ataxia (Dyssynergia)
01/2018 - 03/2005
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2017 - 12/2008
2type 2 Hemochromatosis
12/2015 - 03/2004
2Liver Diseases (Liver Disease)
04/2015 - 01/2010
2Chronic Hepatitis C
01/2010 - 12/2005
2type 3 Hemochromatosis
02/2009 - 05/2004
2Insulin Resistance
10/2004 - 08/2002
1Arthritis (Polyarthritis)
01/2022
1Heart Diseases (Heart Disease)
01/2022
1Kidney Diseases (Kidney Disease)
01/2022
1Lung Diseases (Lung Disease)
01/2022
1Menorrhagia
01/2022
1Muscle Cramp (Cramp)
01/2022
1Pain (Aches)
01/2022
1Rhabdomyolysis
01/2022
1Arthralgia (Joint Pain)
01/2022
1Iron-Deficiency Anemia (Anemia, Iron Deficiency)
01/2022
1Acute Kidney Injury (Acute Renal Failure)
01/2022
1Myalgia
01/2022
1Neurodegeneration with brain iron accumulation (NBIA)
03/2020
1Parkinsonian Disorders (Parkinsonism)
03/2020
1Congenital atransferrinemia
01/2020
1type 4 Hemochromatosis
01/2020
1Retinal Degeneration
01/2018
1Movement Disorders (Movement Disorder)
06/2015
1Nausea
04/2015
1Olfaction Disorders (Cacosmia)
07/2013
1Chronic Disease (Chronic Diseases)
04/2012
1Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
08/2011
1Hepatitis
01/2010
1Sickle Cell Anemia (Hemoglobin S Disease)
10/2009
1Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
07/2009
1Primary Myelofibrosis (Myelosclerosis)
12/2008
1Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2007
1Siderosis
10/2006
1Inflammation (Inflammations)
10/2006
1Basal Ganglia Diseases (Basal Ganglia Disease)
03/2005
1Dementia (Dementias)
03/2005
1Inborn Genetic Diseases (Disease, Hereditary)
03/2004
1Essential Hypertension
08/2002

Drug/Important Bio-Agent (IBA)

42IronIBA
01/2022 - 06/2002
16HepcidinsIBA
01/2020 - 03/2004
14Ferritins (Ferritin)IBA
01/2020 - 08/2002
7Familial apoceruloplasmin deficiencyIBA
03/2020 - 03/2005
6Transferrin (beta 2 Transferrin)IBA
01/2020 - 03/2004
4ErythropoietinFDA Link
12/2014 - 05/2005
3Ceruloplasmin (Ferroxidase)IBA
10/2021 - 03/2005
3metal transporting protein 1 (ferroportin)IBA
01/2020 - 11/2010
2Chelating AgentsIBA
01/2020 - 01/2018
2Retinaldehyde (Retinal)IBA
01/2018 - 01/2018
2DeferasiroxFDA Link
04/2015 - 11/2010
2LipidsIBA
04/2015 - 02/2010
2Proteins (Proteins, Gene)FDA Link
06/2012 - 04/2012
2Peptides (Polypeptides)IBA
04/2012 - 03/2004
2ProgranulinsIBA
08/2011 - 07/2009
2Glucose (Dextrose)FDA LinkGeneric
02/2010 - 06/2002
1ferric gluconate (Ferrlecit)FDA Link
01/2022
1AntibodiesIBA
01/2022
1Dextrans (Dextran)FDA Link
01/2022
1Oxygen (Dioxygen)IBA
01/2022
1CopperIBA
03/2020
1Becaplermin (PDGF-BB)FDA Link
06/2018
1Pharmaceutical PreparationsIBA
01/2018
1ApoferritinsIBA
04/2017
1Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA
07/2016
1Genetic Markers (Genetic Marker)IBA
07/2016
1Transferrin Receptors (Transferrin Receptor)IBA
12/2015
1Antihypertensive Agents (Antihypertensives)IBA
11/2014
1Phospholipases (Phospholipase)IBA
06/2012
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
06/2012
1Insulin-Like Growth Factor I (IGF-1)IBA
03/2011
1Biomarkers (Surrogate Marker)IBA
11/2010
1EnzymesIBA
01/2010
1Transaminases (Aminotransferases)IBA
01/2010
1Dietary IronIBA
10/2009
1Messenger RNA (mRNA)IBA
07/2008
1alpha 1-Antitrypsin (alpha 1 Antitrypsin)IBA
10/2006
1HemosiderinIBA
12/2005
1Nonsense Codon (Nonsense Mutation)IBA
03/2003

Therapy/Procedure

8Therapeutics
01/2022 - 05/2005
3Chelation Therapy (Therapy, Chelation)
01/2018 - 01/2017
1Intramuscular Injections
01/2022
1Transcranial Magnetic Stimulation
03/2020
1Splenectomy
01/2018
1Blood Transfusion (Blood Transfusions)
10/2009